Related Experiment Video
Updated: Jan 20, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
[The German Version of DIALOG+ for Patients with Psychosis - A Pilot Study]
Isabelle Fichtenbauer1, Stefan Priebe2, Beate Schrank1
1Abteilung für Erwachsenenpsychiatrie, Universitätsklinikum Tulln, Karl Landsteiner Privatuniversität für Gesundheitswissenschaften.
Objective:
The pilot study aimed to apply and evaluate the German version of DIALOG+ in patients with psychosis.
Methods:
The German version of DIALOG+ was used with ten patients with psychosis in five sessions each over a 8-week period. DIALOG+ is a brief intervention that is supported by an App, structures clinical routine consultations and helps patients to define and achieve personal goals. For evaluating outcomes, symptom levels, disability and subjective quality of life before and after treatment were compared.
Results:
Adherence was high with a total of 49 of 50 planned sessions completed. Patients showed significant improvements in schizophrenia symptoms (d = 0.88), depressive symptoms (d = 0.85), everyday impairment (d = 0.83) and subjective quality of life (d = 0.12).
Conclusion:
The German version of DIALOG+ provides a feasible and promising approach to make routine meetings therapeutically effective.
Related Concept Videos
Pilot and Numeric Relaying
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Bioavailability Study Design: Healthy Subjects Versus Patients
Patient-centered Care

